Patents Assigned to HANSSEN BIOTECH, INC
  • Patent number: 10611823
    Abstract: FN3 domains that specifically bind to CD137, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: April 7, 2020
    Assignee: HANSSEN BIOTECH, INC
    Inventors: Michael Diem, Rebecca Hawkins, Steven Jacobs, Manuel Sepulveda